Milestones in the Staging, Classification, and Biology of Merkel Cell Carcinoma

Authors: Ata S. Moshiri MD, MPH a , a , a , a and Paul Nghiem MD, PhD a , a , a , a , a
View More View Less
  • a From the School of Medicine, School of Public Health, Institute for Translational Health Sciences, Department of Medicine/Dermatology, and Department of Pathology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center; and Seattle Cancer Care Alliance, Seattle, Washington.
Restricted access

Merkel cell carcinoma (MCC) is an aggressive skin cancer that is causally associated with ultraviolet light exposure and a recently discovered polyomavirus. Before 2010, MCC was staged using any of 5 unique systems in active use. In 2010, a consensus staging system for MCC was adopted worldwide and replaced these systems. This consensus system includes substages that reflect prognostic differences based on whether nodal evaluation was performed by pathologic analysis or clinical assessment alone. MCC-specific disease classification in ICD-9, to be expanded in the upcoming ICD-10, has improved the ability to track and manage this malignancy. Several biomarkers and histopathologic features have been identified that improve understanding of this cancer and may lead to future refinement of the current staging system. In 2008, the Merkel cell polyomavirus was discovered and is now thought to be a critical mechanism of transformation in at least 80% of MCCs. In patients who produce antibodies to the viral T-antigen oncoprotein, the titer increases and decreases with MCC disease burden and can be a clinically useful marker of recurrence. Diverse studies link CD8-positive T-cell function with outcomes in MCC and serve as the rational basis for ongoing trials of therapies to augment cellular immunity. This article reviews basic and translational research insights that will lead to improved staging, prognostic accuracy, and mechanism-based therapy for this often-lethal skin cancer.

Correspondence: Paul Nghiem, MD, PhD, University of Washington, 850 Republican Street, Box 358050, Seattle, WA 98195-8050. E-mail: pnghiem@uw.edu
  • 1.

    Lemos BD, Storer BE, Iyer JG. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751761.

    • Search Google Scholar
    • Export Citation
  • 2.

    Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007;127:21002103.

  • 3.

    Heath M, Jaimes N, Lemos B. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375381.

    • Search Google Scholar
    • Export Citation
  • 4.

    Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:10961100.

  • 5.

    Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10:878889.

  • 6.

    Yiengpruksawan A, Coit DG, Thaler HT. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:15141519.

  • 7.

    Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97105.

  • 8.

    Allen PJ, Bowne WB, Jaques DP. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:23002309.

    • Search Google Scholar
    • Export Citation
  • 9.

    Clark JR, Veness MJ, Gilbert R. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007;29:249257.

  • 10.

    Greene FL, Page DL, Fleming ID. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag; 2002.

  • 11.

    Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.

  • 12.

    Gupta SG, Wang LC, Penas PF. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: rhe Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685690.

    • Search Google Scholar
    • Export Citation
  • 13.

    Iyer JG, Koba S, Nghiem P. Toward better management of merkel cell carcinoma using a consensus staging system, new diagnostic codes and a recently discovered virus. Actas Dermosifiliogr 2009;100(Suppl 2):4954.

    • Search Google Scholar
    • Export Citation
  • 14.

    Popp S, Waltering S, Herbst C. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002;99:352360.

    • Search Google Scholar
    • Export Citation
  • 15.

    Boukamp P. UV-induced skin cancer: similarities—variations. J Dtsch Dermatol Ges 2005;3:493503.

  • 16.

    Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005;571:185205.

  • 17.

    Brewer JD, Shanafelt TD, Otley CC. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol 2012;30:843849.

    • Search Google Scholar
    • Export Citation
  • 18.

    Engels EA, Frisch M, Goedert JJ. Merkel cell carcinoma and HIV infection. Lancet 2002;359:497498.

  • 19.

    Hemminki K, Liu X, Ji J. Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease. Int J Cancer 2012;131:E326328.

  • 20.

    Penn I, First MR. Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999;68:17171721.

  • 21.

    Rodig SJ, Cheng J, Wardzala J. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012;122:46454653.

    • Search Google Scholar
    • Export Citation
  • 22.

    Nicol JT, Robinot R, Carpentier A. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 2013;20:363368.

    • Search Google Scholar
    • Export Citation
  • 23.

    Martel-Jantin C, Pedergnana V, Nicol JT. Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol 2013;58:288291.

    • Search Google Scholar
    • Export Citation
  • 24.

    DeCaprio JA, Garcea RL. A cornucopia of human polyomaviruses. Nat Rev Microbiol 2013;11:264276.

  • 25.

    Houben R, Shuda M, Weinkam R. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010;84:70647072.

    • Search Google Scholar
    • Export Citation
  • 26.

    Carter JJ, Paulson KG, Wipf GC. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009;101:15101522.

    • Search Google Scholar
    • Export Citation
  • 27.

    Paulson KG, Carter JJ, Johnson LG. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 2010;70:83888397.

    • Search Google Scholar
    • Export Citation
  • 28.

    Touze A, Le Bidre E, Laude H. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011;29:16121619.

    • Search Google Scholar
    • Export Citation
  • 29.

    Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008;113:25492558.

  • 30.

    Ng L, Beer TW, Murray K. Vascular density has prognostic value in Merkel cell carcinoma. Am J Dermatopathol 2008;30:442445.

  • 31.

    Fields RC, Busam KJ, Chou JF. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011;254:465473.

  • 32.

    Kukko HM, Koljonen VS, Tukiainen EJ. Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Mod Pathol 2010;23:11511156.

    • Search Google Scholar
    • Export Citation
  • 33.

    Paulson KG, Iyer JG, Blom A. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol 2013;133:642646.

    • Search Google Scholar
    • Export Citation
  • 34.

    Johnson ME, Zhu F, Li T. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. J Am Acad Dermatol 2014;70:10281035.

    • Search Google Scholar
    • Export Citation
  • 35.

    Paulson KG, Iyer JG, Tegeder AR. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011;29:15391546.

    • Search Google Scholar
    • Export Citation
  • 36.

    Sihto H, Bohling T, Kavola H. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study. Clin Cancer Res 2012;18:28722881.

    • Search Google Scholar
    • Export Citation
  • 37.

    Afanasiev OK, Yelistratova L, Miller N. Merkel polyomavirus-specific T cells fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clin Cancer Res 2013;19:53515360.

    • Search Google Scholar
    • Export Citation
  • 38.

    Lipson EJ, Vincent JG, Loyo M. PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus, and overall survival. Cancer Immunology Research 2013;1:5463.

    • Search Google Scholar
    • Export Citation
  • 39.

    Veness MJ, Perera L, McCourt J. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg 2005;75:275281.

  • 40.

    Foote M, Veness M, Zarate D, Poulsen M. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol 2012;67:395399.

    • Search Google Scholar
    • Export Citation
  • 41.

    Deneve JL, Messina JL, Marzban SS. Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol 2012;19:23602366.

  • 42.

    Chen KT, Papavasiliou P, Edwards K. A better prognosis for Merkel cell carcinoma of unknown primary origin. Am J Surg 2013;206:752757.

  • 43.

    Tarantola TI, Vallow LA, Halyard MY. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol 2013;68:433440.

  • 44.

    Yao JY, Chen JK. Roles of p63 in epidermal development and tumorigenesis. Biomed J 2012;35:457463.

  • 45.

    Asioli S, Righi A, de Biase D. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Mod Pathol 2011;24:14511461.

    • Search Google Scholar
    • Export Citation
  • 46.

    Hall BJ, Pincus LB, Yu SS. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol 2012;39:911917.

    • Search Google Scholar
    • Export Citation
  • 47.

    Stetsenko GY, Malekirad J, Paulson KG. p63 Expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Am J Clin Pathol 2013;140:838844.

    • Search Google Scholar
    • Export Citation
  • 48.

    Bichakjian CK, Olencki T, Alam M. NCCN Clinical Practice Guidelines in Oncology: Merkel Cell Carcinoma. Version 1, 2014. Available at: NCCN.org. Accessed July 30, 2014.

    • Search Google Scholar
    • Export Citation
  • 49.

    Miller NJ, Bhatia S, Parvathaneni U. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol 2013;14:249263.

    • Search Google Scholar
    • Export Citation
  • 50.

    Topalian SL, Hodi FS, Brahmer JR. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:24432454.

  • 51.

    Brahmer JR, Tykodi SS, Chow LQ. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012;366:245565.

  • 52.

    Fisher TS, Kamperschroer C, Oliphant T. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity. Cancer Immunol Immunother 2012;61:17211733.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 308 188 6
PDF Downloads 19 10 0
EPUB Downloads 0 0 0